Search

everythinglearnresearchcommunity

for

Search:↓

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Alkaloids show promise in treating cholangiocarcinoma by effectively targeting cancer cells.

Birth control pills can help reduce mild to moderate acne in women.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Chlormadinone acetate is useful for birth control and treating various hormonal issues.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

Danthron from Rhubarb causes melanoma cells to stop growing and die.

Compound 1 showed promising anticancer activity.

New compounds may help treat prostate cancer by reducing cell growth.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Iron chloride helps create compounds that could be useful in medicine, like treating hair loss.

Prostaglandins may protect hair follicles during chemotherapy.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

The document concludes that scientists created various steroids with different properties, including a more effective semi-synthetic vitamin D.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.